Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002914944 | SCV003266810 | likely benign | Hereditary spastic paraplegia 2 | 2024-02-07 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV003134549 | SCV003811193 | uncertain significance | not provided | 2021-02-17 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004958855 | SCV005474422 | uncertain significance | Inborn genetic diseases | 2024-10-29 | criteria provided, single submitter | clinical testing | The c.578C>A (p.T193N) alteration is located in exon 4 (coding exon 4) of the PLP1 gene. This alteration results from a C to A substitution at nucleotide position 578, causing the threonine (T) at amino acid position 193 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |